These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 30250824)
1. Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event. Capp JP; Bataille R Front Oncol; 2018; 8():355. PubMed ID: 30250824 [TBL] [Abstract][Full Text] [Related]
2. The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis. Capp JP; Bataille R Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508420 [TBL] [Abstract][Full Text] [Related]
3. Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory. Capp JP; Bataille R Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759688 [TBL] [Abstract][Full Text] [Related]
4. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS. Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600 [TBL] [Abstract][Full Text] [Related]
5. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ]. Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602 [TBL] [Abstract][Full Text] [Related]
7. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance. Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187 [TBL] [Abstract][Full Text] [Related]
8. Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma. Bianchi G; Ghobrial IM Curr Cancer Ther Rev; 2014; 10(2):70-79. PubMed ID: 25705146 [TBL] [Abstract][Full Text] [Related]
9. The bone-marrow niche in MDS and MGUS: implications for AML and MM. Ghobrial IM; Detappe A; Anderson KC; Steensma DP Nat Rev Clin Oncol; 2018 Apr; 15(4):219-233. PubMed ID: 29311715 [TBL] [Abstract][Full Text] [Related]
11. MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology. Mateos MV; Landgren O Cancer Treat Res; 2016; 169():3-12. PubMed ID: 27696254 [TBL] [Abstract][Full Text] [Related]
12. New insights into role of microenvironment in multiple myeloma. Tricot GJ Int J Hematol; 2002 Aug; 76 Suppl 1():334-6. PubMed ID: 12430876 [TBL] [Abstract][Full Text] [Related]
13. The multiple myeloma bone eco-system and its relation to oncogenesis. Bataille R Morphologie; 2015 Jun; 99(325):31-7. PubMed ID: 26005000 [TBL] [Abstract][Full Text] [Related]
14. Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis. Gámez B; Edwards CM Curr Osteoporos Rep; 2018 Dec; 16(6):635-641. PubMed ID: 30229522 [TBL] [Abstract][Full Text] [Related]
15. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome. Avet-Loiseau H; Facon T; Daviet A; Godon C; Rapp MJ; Harousseau JL; Grosbois B; Bataille R Cancer Res; 1999 Sep; 59(18):4546-50. PubMed ID: 10493504 [TBL] [Abstract][Full Text] [Related]
16. Endosteal and Perivascular Subniches in a 3D Bone Marrow Model for Multiple Myeloma. Braham MVJ; Ahlfeld T; Akkineni AR; Minnema MC; Dhert WJA; Öner FC; Robin C; Lode A; Gelinsky M; Alblas J Tissue Eng Part C Methods; 2018 May; 24(5):300-312. PubMed ID: 29652626 [TBL] [Abstract][Full Text] [Related]
17. Role of cytokines in the pathogenesis of monoclonal gammopathies. Lust JA Mayo Clin Proc; 1994 Jul; 69(7):691-7. PubMed ID: 8015336 [TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070 [TBL] [Abstract][Full Text] [Related]